|
Phenotypic drug discovery is successful strategy that allows to identify substances (small molecules, peptides etc.) which alter the phenotype of cells, tissues or whole organisms in a desired manner.
|
|
Read more...
|
|
Embark on a new era of drug discovery as OTAVA’s CHEMRIYA™ Virtual Chemical Space integrates with CHEESE Search, the advanced AI-powered platform by Deep MedChem.
Unparalleled Chemical Diversity:
Access a subset of CHEMRIYA™, a next-generation virtual chemical space tailored for hit expansion, hit-to-lead, and lead optimization.
|
|
Read more...
|
 Natural Product-Like Library has been designed as a special screening library containing synthetic compounds similar to natural products.
|
|
Read more...
|
|
|
 Fragment-based lead design (FBLD) could be used to identify new metal-binding groups for metalloenzyme inhibitors. Several small-molecule chelators have been shown to effectively inhibit metalloproteins, therefore the design,
|
|
Read more...
|
|
The Targeted AHR Modulator Library is a curated chemical screening set designed to accelerate the discovery of novel small-molecule modulators of the aryl hydrocarbon receptor (AHR) — a ligand-dependent transcription factor with key roles in immunity, cancer, inflammation, and xenobiotic metabolism.
This unique compound library supports early-stage discovery, target validation, and therapeutic innovation by providing access to structurally diverse and computationally prioritized molecules tailored for AHR-centric research and drug development programs.
|
|
Read more...
|
|
|
|
|
|
|
Page 3 of 16 |
HOME
Overview
